Jeffrey Eisele - 22 Jan 2025 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Signature
/s/ David Watson, attorney-in-fact for Jeffrey Eisele
Issuer symbol
APLS
Transactions as of
22 Jan 2025
Transactions value $
$-39,279
Form type
4
Filing time
23 Jan 2025, 15:26:42 UTC
Previous filing
14 Jan 2025
Next filing
30 Jan 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale $-39,279 -1,291 -2.27% $30.43 55,590 22 Jan 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents shares sold to cover tax withholding on the Restricted Stock Units released on January 21, 2025.